The stability of this material in solution has not been investigated. However, other sources indicate that this compound is soluble in water at >35 mg/mL as well as in DMSO up to 65 mg/mL and Ethanol up to 22 mg/mL. Stock solutions may be stable for 1 month at -20°C and possibly 6 – 12 months at -80°C. Avoid repeated freeze/thaw cycles. This information has not been validated.
Fortfahren mit
B8299
N-Butyldeoxynojirimycin
film (dried in situ), ≥98% (TLC)
Synonym(e):
Miglustat, NB-DNJ
Anmelden zur Ansicht der Organisations- und Vertragspreise.
Größe auswählen
Ansicht ändern
| Ihnen/SKU | Verfügbarkeit | Preis |
|---|---|---|
1 mg | Warenkorb auf Verfügbarkeit prüfen | € 419,00 |
5 mg | Warenkorb auf Verfügbarkeit prüfen | € 1.560,00 |
Über diesen Artikel
Empirische Formel (Hill-System):
C10H21NO4
CAS-Nummer:
Molekulargewicht:
219.28
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.32
MDL number:
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhaltenProduktname
N-Butyldeoxynojirimycin, film (dried in situ)
assay
≥98% (TLC)
Quality Segment
form
film (dried in situ)
solubility
water: 9.80-10.20 mg/mL, clear, colorless
storage temp.
2-8°C
SMILES string
CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
InChI
1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1
InChI key
UQRORFVVSGFNRO-UTINFBMNSA-N
Gene Information
human ... UGCG(7357)
General description
N-Butyldeoxynojirimycin is an alkylated product of imino sugar deoxynojirimycin.
Application
N-Butyldeoxynojirimycin has been used:
- in the inhibition of glycolipid synthesis in neuroblastoma cells
- in the inhibition the ceramide-specific glycosyltransferase in hepatocytes
- in the inhibition of β-glucosidase (GBA2) using fluorescence- activity assay in human embryonic kidney (HEK293) cells.[1]
Biochem/physiol Actions
α-glucosidase Inhibitor
N-Butyldeoxynojirimycin is an inhibitor of glucosyltransferase and α-glucosidases. N-Butyldeoxynojirimycin, also known as misglustat, reduces glycolipid levels by substrate reduction therapy (SRT) and is effectively used for the treatment of glycosphingolipid lysosomal storage disorder, Gaucher disease.
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| assay ≥98% (TLC) | assay ≥98% (TLC) | assay ≥98% (TLC) | assay ≥97% (HPLC) |
| Gene Information human ... UGCG(7357) | Gene Information - | Gene Information - | Gene Information - |
| Quality Level 200 | Quality Level 200 | Quality Level 200 | Quality Level 100 |
| form film (dried in situ) | form powder | form powder | form solid |
| solubility water: 9.80-10.20 mg/mL, clear, colorless | solubility DMSO: 9.80-10.20 mg/mL, clear to slightly hazy, colorless to yellow | solubility DMF: 9.80-10.20 mg/mL, clear, colorless to light yellow | solubility water: 50 mg/mL |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. −20°C | storage temp. −20°C |
Lagerklasse
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
-
How long is B8299 stable when dissolved in water, and at what temperature can I store it when it is in solution?
1 answer-
Helpful?
-